Vaccine Monitoring Platform: List of EMA-funded studies

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 25, Status: Authorised

PSUSA00001858202409

Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Status: Authorised

Evrysdi

Human medicines European public assessment report (EPAR): Votubia, everolimus, Date of authorisation: 02/09/2011, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Esmya, ulipristal, Date of authorisation: 22/02/2012, Revision: 16, Status: Withdrawn

Human medicines European public assessment report (EPAR): Raxone, idebenone, Date of authorisation: 08/09/2015, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 19, Status: Authorised